User:Mr. Ibrahem/Triheptanoin

Triheptanoin, sold under the brand name Dojolvi, is a medication used to treat long-chain fatty acid oxidation disorders (LC-FAOD). This includes pyruvate carboxylase deficiency and carnitine palmitoyltransferase II deficiency. It is taken by mouth.

Common side effects include abdominal pain, diarrhea, vomiting, and nausea. In those with pancreatic insufficiency intestinal malabsorption may occur. It is a manufactured medium-chain triglyceride and is a source of calories and fatty acids.

Triheptanoin was approved for medical use in the United States in 2020. As of 2022 it is not approved in Europe or the United Kingdom. In the United States it costs about 5,600 USD for 500 ml as of 2022.